MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.760
-0.120 (-4.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $173.23 million as of February 21, 2025. Its market cap has decreased by -83.33% in one year.
Market Cap
173.23M
Enterprise Value
6.96M
1-Year Change
-83.33%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $173.23M, a decrease of -71.14%. That is a compound annual growth rate of -10.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 180.80M | -11.37% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |